These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29100312)

  • 21. Antitumour immunity invoked by hepatic arterial infusion of first-line oxaliplatin predicts durable colorectal cancer control after liver metastasis ablation: 8-12 years of follow-up.
    Abrahamsson H; Jensen BV; Berven LL; Nielsen DL; Šaltytė Benth J; Johansen JS; Larsen FO; Johansen JS; Ree AH
    Int J Cancer; 2020 Apr; 146(7):2019-2026. PubMed ID: 31872440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.
    Ros J; Baraibar I; Martini G; Salvà F; Saoudi N; Cuadra-Urteaga JL; Dienstmann R; Tabernero J; Élez E
    Curr Treat Options Oncol; 2021 Nov; 22(12):113. PubMed ID: 34741675
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
    Daemen A; Udyavar AR; Sandmann T; Li C; Bosch LJW; O'Gorman W; Li Y; Au-Yeung A; Takahashi C; Kabbarah O; Bourgon R; Hegde P; Bais C; Das Thakur M
    PLoS One; 2021; 16(12):e0262198. PubMed ID: 34972191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Adding Bevacizumab to Chemotherapy on Pathologic Response to Preoperative Systemic Therapy for Resectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
    Jácome AA; Oliveira FA; Lino F; Lima JPSN
    Clin Colorectal Cancer; 2021 Sep; 20(3):265-272. PubMed ID: 34158251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Consensus Molecular Subtypes and Molecular Markers With Clinical Outcomes in Patients With Metastatic Colorectal Cancer: Biomarker Analyses From LUME-Colon 1.
    Lenz HJ; Argiles G; Yoshino T; Tejpar S; Ciardiello F; Braunger J; Salnikov AV; Gabrielyan O; Schmid R; Höfler J; Kitzing T; Van Cutsem E
    Clin Colorectal Cancer; 2021 Mar; 20(1):84-95.e8. PubMed ID: 33041226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLM.
    Ma YS; Wu ZJ; Zhang HW; Cai B; Huang T; Long HD; Xu H; Zhao YZ; Yin YZ; Xue SB; Li L; Liu CL; Xie RT; Tian LL; Liu JB; Wu XM; Fu D
    Mol Ther Oncolytics; 2019 Sep; 14():172-178. PubMed ID: 31236441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current state of surgical treatment of liver metastases from colorectal cancer.
    Grundmann RT
    World J Gastrointest Surg; 2011 Dec; 3(12):183-96. PubMed ID: 22224173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker.
    Lin AY; Chua MS; Choi YL; Yeh W; Kim YH; Azzi R; Adams GA; Sainani K; van de Rijn M; So SK; Pollack JR
    PLoS One; 2011 Feb; 6(2):e16636. PubMed ID: 21383983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases.
    Zhang T; Yuan K; Wang Y; Xu M; Cai S; Chen C; Ma J
    Front Oncol; 2021; 11():652354. PubMed ID: 34422629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-institutional analysis of outcomes for thermosphere microwave ablation treatment of colorectal liver metastases: the SMAC study.
    De Cobelli F; Calandri M; Della Corte A; Sirovich R; Gazzera C; Della Vigna P; Bonomo G; Varano GM; Maiettini D; Mauri G; Camisassi N; Steidler S; Ratti F; Gusmini S; Ronzoni M; Aldrighetti L; Odisio BC; Racca P; Fonio P; Veltri A; Orsi F
    Eur Radiol; 2022 Jun; 32(6):4147-4159. PubMed ID: 35092474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copy number profiles of paired primary and metastatic colorectal cancers.
    Kawamata F; Patch AM; Nones K; Bond C; McKeone D; Pearson SA; Homma S; Liu C; Fennell L; Dumenil T; Hartel G; Kobayasi N; Yokoo H; Fukai M; Nishihara H; Kamiyama T; Burge ME; Karapetis CS; Taketomi A; Leggett B; Waddell N; Whitehall V
    Oncotarget; 2018 Jan; 9(3):3394-3405. PubMed ID: 29423054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of Gene Co-Expression Networks Associated with Consensus Molecular Subtype-1 of Colorectal Cancer.
    Nunez SK; Young CD; Griffen TL; Ohandjo AQ; McKinney LP; Kopetz S; Lillard JW
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing.
    Mogensen MB; Rossing M; Østrup O; Larsen PN; Heiberg Engel PJ; Jørgensen LN; Hogdall EV; Eriksen J; Ibsen P; Jess P; Grauslund M; Nielsen HJ; Nielsen FC; Vainer B; Osterlind K
    BMC Cancer; 2018 Jul; 18(1):752. PubMed ID: 30029640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoadjuvant chemotherapy affects molecular classification of colorectal tumors.
    Trumpi K; Ubink I; Trinh A; Djafarihamedani M; Jongen JM; Govaert KM; Elias SG; van Hooff SR; Medema JP; Lacle MM; Vermeulen L; Borel Rinkes IHM; Kranenburg O
    Oncogenesis; 2017 Jul; 6(7):e357. PubMed ID: 28692036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic mutations associated with sensitivity to neoadjuvant chemotherapy in metastatic colon cancer: A case report and review of literature.
    Zhao L; Wang Q; Zhao SD; Zhou J; Jiang KW; Ye YJ; Wang S; Shen ZL
    World J Clin Cases; 2021 Aug; 9(24):7099-7109. PubMed ID: 34540965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy accelerates immune-senescence and functional impairments of Vδ2
    Bruni E; Cazzetta V; Donadon M; Cimino M; Torzilli G; Spata G; Leonardi G; Dieli F; Mikulak J; Mavilio D
    J Immunother Cancer; 2019 Dec; 7(1):347. PubMed ID: 31829255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic stratification beyond Ras/B-Raf in colorectal liver metastasis patients treated with hepatic arterial infusion.
    Smith JJ; Chatila WK; Sanchez-Vega F; Datta J; Connell LC; Szeglin BC; Basunia A; Boucher TM; Hauser H; Wasserman I; Wu C; Cercek A; Hechtman JF; Madden C; Jarnagin WR; Garcia-Aguilar J; D'Angelica MI; Yaeger R; Schultz N; Kemeny NE
    Cancer Med; 2019 Nov; 8(15):6538-6548. PubMed ID: 31503397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Adjuvant Chemotherapy According to the Classification of Recurrence Risk Based on Systemic Inflammatory Markers in Patients With Liver Metastases of Colorectal Cancer.
    Shibutani M; Nagahara H; Fukuoka T; Iseki Y; Hirakawa K; Ohira M
    Anticancer Res; 2019 Sep; 39(9):5039-5045. PubMed ID: 31519612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases.
    Nishioka Y; Shindoh J; Inagaki Y; Gonoi W; Mitsui J; Abe H; Yoshioka R; Yoshida S; Fukayama M; Tsuji S; Hashimoto M; Hasegawa K; Kokudo N
    Dig Dis; 2018; 36(6):437-445. PubMed ID: 29969766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary Colorectal Tumor Displays Differential Genomic Expression Profiles Associated with Hepatic and Peritoneal Metastases.
    Gelli M; Desterke C; Bani MA; Boige V; Ferté C; Dartigues P; Job B; Perkins G; Laurent-Puig P; Goéré D; Mathieu JRR; Cartry J; Ducreux M; Jaulin F
    Cancers (Basel); 2023 Sep; 15(17):. PubMed ID: 37686695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.